C07D 471/12
In which the condensed system contains three hetero rings
Official title: in which the condensed system contains three hetero rings
C07D471/12 (In which the condensed system contains three hetero rings) appears on 2,522 US grants and 3,077 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,522
- Published applications
- 3,077
- Assignees
- 1,168
- Inventors
- 8,752
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 14 | 0 |
| 1978 | 13 | 0 |
| 1979 | 7 | 0 |
| 1980 | 7 | 0 |
| 1981 | 8 | 0 |
| 1982 | 14 | 0 |
| 1983 | 8 | 0 |
| 1984 | 12 | 0 |
| 1985 | 8 | 0 |
| 1986 | 12 | 0 |
| 1987 | 16 | 0 |
| 1988 | 25 | 0 |
| 1989 | 29 | 0 |
| 1990 | 20 | 0 |
| 1991 | 27 | 0 |
| 1992 | 16 | 0 |
| 1993 | 26 | 0 |
| 1994 | 26 | 0 |
| 1995 | 24 | 0 |
| 1996 | 26 | 0 |
| 1997 | 29 | 0 |
| 1998 | 19 | 0 |
| 1999 | 23 | 0 |
| 2000 | 33 | 0 |
| 2001 | 31 | 9 |
| 2002 | 37 | 48 |
| 2003 | 43 | 65 |
| 2004 | 38 | 92 |
| 2005 | 46 | 64 |
| 2006 | 40 | 58 |
| 2007 | 47 | 79 |
| 2008 | 31 | 80 |
| 2009 | 37 | 99 |
| 2010 | 41 | 108 |
| 2011 | 71 | 125 |
| 2012 | 72 | 111 |
| 2013 | 105 | 118 |
| 2014 | 105 | 126 |
| 2015 | 127 | 152 |
| 2016 | 119 | 128 |
| 2017 | 122 | 142 |
| 2018 | 120 | 133 |
| 2019 | 102 | 158 |
| 2020 | 104 | 162 |
| 2021 | 115 | 150 |
| 2022 | 106 | 173 |
| 2023 | 88 | 185 |
| 2024 | 136 | 198 |
| 2025 | 115 | 184 |
| 2026 | 70 | 130 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Spirotricycle RIPK1 inhibitors and methods of uses thereof6 Oct 2026US 12,753,190 B2Merck Sharp & Dohme Corp.
- Organic light emitting diode and organic light emitting display device including the same6 Oct 2026US 12,757,570 B2LG Display Co., Ltd.
- Indirubin derivatives having heterobicyclic moieties and the use thereof15 Sep 2026US 12,735,404 B2Pelemed Co., Ltd.
- MALT-1 modulators8 Sep 2026US 12,729,201 B2Recursion Pharmaceuticals, Inc.
- Heterocyclic substituted fused γ-carboline derivative, preparation method therefor, intermediate thereof and use thereof1 Sep 2026US 12,723,044 B2Jiangsu Nhwa Pharmaceutical Co., Ltd
- Organic compounds8 Oct 2026US 2026/0306489 A1Intra-Cellular Therapies, Inc.
- Anti-inflammatory compounds, pharmaceutical compositions, and methods of treating hemochromatosis and other disorders8 Oct 2026US 2026/0308181 A1Miralogx LLC
- Kif18a inhibitor compound, and pharmaceutical composition and preparation method therefor and use thereof1 Oct 2026US 2026/0294927 A1Changchun Genescience Pharmaceutical Co., Ltd.
- Inhibitors of cyclin-dependent kinase (cdk) 12 and/or cdk13 and uses thereof1 Oct 2026US 2026/0297091 A1Insilico Medicine IP Limited
- Tetracyclic Compounds as SMARCA2 and/or SMARCA4 Degraders1 Oct 2026US 2026/0297094 A1Aurigene Oncology Limited
Most cited
By later US patents
- Imidazo[4,5-C]quinoline amines264US 5,482,936 AMinnesota Mining and Manufacturing Company · 1996
- Imidazonaphthyridines255US 6,194,425 B13M Innovative Properties Company · 2001
- Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family225US 5,654,307 AWarner-Lambert Company · 1997
- Benzimisazo[4,5-f]isoquinolinone derivatives168US 6,852,727 B2Merck & Co., Inc. · 2005
- 1H-imidazo dimers134US 6,818,650 B23M Innovative Properties Company · 2004